XML 33 R71.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Payment Awards - Performance-Based Stock Units - Additional Information (Detail) - Performance Stock Units [Member] - shares
12 Months Ended
Oct. 12, 2019
Mar. 19, 2019
Oct. 12, 2018
Mar. 19, 2018
Dec. 31, 2019
Dec. 31, 2018
Former Chief Financial Officer [Member]            
Class of Stock [Line Items]            
Cumulative measurement period         3 years  
Resignation date of employee         Jul. 08, 2019  
Long Term Incentive Plan [Member]            
Class of Stock [Line Items]            
Number of Stock Units Outstanding         0 225,000
Performance Condition One [Member]            
Class of Stock [Line Items]            
Portion of stock units subject to an FDA acceptance of the Company's NDA submission of YUTIQ for review on or before March 31, 2018         One third  
Stock units vesting, percentage   50.00%   50.00%    
Number of Performance-Based Stock Units, vested       48,332    
Number of performance-based stock units subject to service-based vesting of one year from performance condition achievement date   48,334        
Performance Condition Two [Member]            
Class of Stock [Line Items]            
Portion of stock units subject to an FDA approval of YUTIQ on or before March 31, 2019         Two-thirds  
Stock units vesting, percentage 50.00%   50.00%      
Number of Performance-Based Stock Units, vested     96,668      
Number of performance-based stock units subject to service-based vesting of one year from performance condition achievement date 96,666          
Inducement Award Grants [Member] | Former Chief Financial Officer [Member]            
Class of Stock [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award         The PSUs are subject to proportional vesting based on cumulative measurement over a 3-year period, with two-thirds of the award based upon the achievement of defined amounts of the Company’s product revenues through June 30, 2021 and one-third of the award based upon the net present value of each applicable business development transaction, as defined, through August 1, 2021 measured as of the date that each such transaction is consummated by the Company.